Dimensional Fund Advisors
TARA icon

Dimensional Fund Advisors’s Protara Therapeutics TARA Stock Holding History

Dimensional Fund Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
683,230
+151,963
+29% +$723K ﹤0.01% 2682
2026
Q1 		$2.77M Buy
531,267
+304,110
+134% +$1.8M ﹤0.01% 2637
2025
Q4 		$1.21M Buy
227,157
+179,449
+376% +$998K ﹤0.01% 2835
2025
Q3 		$208K Sell
47,708
-37,595
-44% -$122K ﹤0.01% 3113
2025
Q2 		$258K Buy
85,303
+15,700
+23% +$54.2K ﹤0.01% 3082
2025
Q1 		$297K Buy
69,603
+48,606
+231% +$217K ﹤0.01% 3080
2024
Q4 		$111K Buy
+20,997
New +$67.8K ﹤0.01% 3232
2024
Q2 		– Sell
-12,126
Closed -$48.6K – 3406
2024
Q1 		$48.6K Buy
+12,126
New +$39.1K ﹤0.01% 3333
2023
Q4 		– Sell
-13,821
Closed -$23.1K – 3453
2023
Q3 		$23.1K Sell
13,821
-4,931
-26% -$11.3K ﹤0.01% 3436
2023
Q2 		$44.8K Buy
18,752
+1,918
+11% +$5.7K ﹤0.01% 3415
2023
Q1 		$52.2K Buy
+16,834
New +$55.6K ﹤0.01% 3380
2022
Q3 		$47K Sell
15,782
-12,918
-45% -$43.8K ﹤0.01% 3411
2022
Q2 		$84K Sell
28,700
-1,906
-6% -$6.97K ﹤0.01% 3349
2022
Q1 		$156K Sell
30,606
-2,868
-9% -$15.1K ﹤0.01% 3341
2021
Q4 		$226K Buy
+33,474
New +$231K ﹤0.01% 3326
2018
Q3 		– Sell
-464
Closed -$45K – 3437
2018
Q2 		$45K Hold
464
– – ﹤0.01% 3341
2018
Q1 		$46K Hold
464
– – ﹤0.01% 3316
2017
Q4 		$35K Hold
464
– – ﹤0.01% 3310
2017
Q3 		$37K Buy
+464
New +$26.5K ﹤0.01% 3312

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Dimensional Fund Advisors's TARA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Protara Therapeutics (TARA) stake by 29% in Q2 2026, buying an estimated $723K and bringing the position to 683,230 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Dimensional Fund Advisors first reported a position in TARA in Q3 2017 and has held it in 19 quarters since. The position peaked at $2.77M in Q1 2026. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Dimensional Fund Advisors held 683,230 shares of Protara Therapeutics worth $2.61M as of Q2 2026.
  • Dimensional Fund Advisors bought 151,963 Protara Therapeutics shares in Q2 2026, an estimated $723K.
  • Protara Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2682 holding.
  • Dimensional Fund Advisors first reported a position in Protara Therapeutics in Q3 2017 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Protara Therapeutics position peaked at $2.77M in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.